Adnkronos "Vaccination against respiratory syncytial virus (RSV) has proven to be an effective method for reducing acute events in patients with chronic obstructive pulmonary disease (COPD) or asthma, as well as in patients with cardiovascular disease, particularly heart failure and diabetes." This was stated by Dejan Radovanovic, Professor of Respiratory Diseases at the University of Milan and Medical Director of the Pulmonology Unit at the Luigi Sacco Hospital, Fatebenefratelli Sacco Hospital, Milan, at a press conference in Milan organized by GSK during International Respiratory Syncytial Virus (RSV) Awareness Week, from November 2 to 8.
https://www.youtube.com/watch?v=bRr4vNzqiAk
Continue on the app
The news of your city, in real time.
Open in app